Medical Health Cluster

SARS-CoV-2

Rapid induction of antigen-specific CD4+ T cells guides coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination

Summary The SARS-CoV-2 mRNA vaccines have shown remarkable clinical efficacy, but questions remain about the nature and kinetics of T cell priming. We performed longitudinal antigen-specific T cell analyses in healthy individuals following mRNA vaccination. Vaccination induced rapid near-maximal antigen-specific CD4+ T cell responses in all subjects after the first vaccine […]

Read More

SARS-CoV-2 Positivity on or After 9 Days Among Quarantined Student Contacts of Confirmed Cases

Schools reopened during the fall of 2020 with various approaches to mitigate SARS-CoV-2 infection. At that time, the US Centers for Disease Control and Prevention (CDC) recommended a 14-day quarantine without testing for close contacts of anyone diagnosed with COVID-19. However, data indicated that the incubation period for SARS-CoV-2 infection […]

Read More

Nueva clasificación de riesgo de las variantes del SARS-CoV-2

Centers for Disease Control and Prevention (CDC) de Estados Unidos y la Organización Mundial de la Salud (OMS) han establecido nuevos criterios para clasificar las variantes del SARS-CoV-2, el virus que causa la COVID-19. Las nuevas designaciones son: variante de interés, variante de preocupación y variante de gran consecuencia. Una […]

Read More